Zobrazeno 1 - 10
of 23
pro vyhledávání: '"J. P. Kiley"'
Autor:
D. R. Hill, Claude Bouchard, James R. Sowers, Linda Snetselaar, Shiriki K. Kumanyika, R. D. Legako, Michael J. Horan, J. P. Kiley, E. Chiquette, Barbara C. Hansen, Diane M. Becker, Robert J. Kuczmarski, F. X. Pi-Sunyer, Graham A. Colditz, Van S. Hubbard, William H. Dietz, Barbara V. Howard, R. J. Garrison, A. P. Rocchini, D. Shriger, Scott M. Grundy, Don Williamson, G. T. Wilson, Clinton D. Brown, Millicent Higgins, Philip L. Smith, John P. Foreyt, T. E. Prewitt, James O. Hill, Richard A. Carleton, Karen A. Donato, Nancy D. Ernst, M. Weintrub, Eva Obarzanek
Publikováno v:
Scopus-Elsevier
Publikováno v:
Journal of Applied Physiology. 69:1916-1920
A function shared by both respiratory and cardiovascular systems is the delivery of metabolic substrate (e.g., oxygen) and removal of metabolic waste products (e.g., carbon dioxide) from tissue.
Autor:
S, Redline, M H, Sanders, B K, Lind, S F, Quan, C, Iber, D J, Gottlieb, W H, Bonekat, D M, Rapoport, P L, Smith, J P, Kiley
Publikováno v:
Sleep. 21(7)
This paper reviews the data collection, processing, and analysis approaches developed to obtain comprehensive unattended polysomnographic data for the Sleep Heart Health Study, a multicenter study of the cardiovascular consequences of sleep-disordere
Autor:
S F, Quan, B V, Howard, C, Iber, J P, Kiley, F J, Nieto, G T, O'Connor, D M, Rapoport, S, Redline, J, Robbins, J M, Samet, P W, Wahl
Publikováno v:
Sleep. 20(12)
The Sleep Heart Health Study (SHHS) is a prospective cohort study designed to investigate obstructive sleep apnea (OSA) and other sleep-disordered breathing (SDB) as risk factors for the development of cardiovascular disease. The study is designed to
Autor:
R P, Murray, W C, Bailey, K, Daniels, W M, Bjornson, K, Kurnow, J E, Connett, M A, Nides, J P, Kiley
Publikováno v:
Chest. 109(2)
To assess cardiovascular conditions and other side effects associated with the use of nicotine polacrilex (NP), 2 mg.A multicentered randomized control trial of early intervention for the prevention of COPD.Ten university medical centers in the Unite
Autor:
N R, Anthonisen, J E, Connett, J P, Kiley, M D, Altose, W C, Bailey, A S, Buist, W A, Conway, P L, Enright, R E, Kanner, P, O'Hara
Publikováno v:
JAMA. 272(19)
To determine whether a program incorporating smoking intervention and use of an inhaled bronchodilator can slow the rate of decline in forced expiratory volume in 1 second (FEV1) in smokers aged 35 to 60 years who have mild obstructive pulmonary dise
Publikováno v:
The Physiologist. 33(2)
Autor:
M. Roth, G. L. Snider, J. A. Reddick, J. K. Ockene, James P. Kiley, M. A. Johnson, V. C. Roth, G. M. Caron, William A. Conway, C. Sawicki, J. M. Stoyko, R. E. Kanner, R. P. Murray, R. D. Hurt, S. Permutt, M. O. Kjelsberg, P. Kimbel, A. S. Buist, L. Nett, D. P. Tashkin, W. W. Lee, John E. Connett, J. E. Connett, Gregory R. Owens, L. R. Johnson, Lance A. Waller, Robert A. Wise, R. M. Senior, F. M. Vitale, J. J. Johnston, N. R. Anthonisen, P. D. Scanlon, Murray D. Altose, C. S. Hoppe Ryan, R. L. Jentons, S. C. Rempel Rossum, I. Zuniga, R. M. Rogers, William C. Bailey, G. G. Lauger, M. A. Rigdon, W. A. Conway, K. J. Kurnow, S. M. Ayres, F. P. Pope, Alfred F Connors, R. A. Wise, Benjamin A. Mason, D. M. Higgins, M. K. Cowles, Paul D. Scanlon, R. F. Rakos, Peggy O'Hara, S. S. Hurd, J. Manfreda, P. Cleary, W. C. Bailey, S. M. Toogood, Paul L. Enright, R. E. Hyatt, P. O'hara, P. M. Grant, B. A. Martin, K. C. Benton, C. Deitz, O. D. Williams, S. J. Mongin, H. T. Voelker, Mitchell A. Nides, G. R. Owens, A. Dehorn, M. D. Altose, Donald P. Tashkin, P. L. Enright, D. E. Williams, Philip Harber, W. Spitzer, R. D. Miller, L. J. Davis, H. Gong, C. D. Lorish, J. C. Ward, M. Becklake, M. C. Ayres, A. Sonia Buist, Susan Redline, Nicholas R. Anthonisen, Cynthia S. Rand, Benjamin Burrows, M. S. Simmons, A. H. Coulson, W. M. Bjornson, C. M. Brooks, J. P. Kiley, D. A. Durkin, J. J. Dolce, P. G. Lindgren, Richard E. Kanner
Publikováno v:
JAMA. 272:1497
Objective. —To determine whether a program incorporating smoking intervention and use of an inhaled bronchodilator can slow the rate of decline in forced expiratory volume in 1 second (FEV1) in smokers aged 35 to 60 years who have mild obstructive